The objective is to generate additional TBV monoclonal antibodies (mAbs) by immunizing mice with gamete membrane preparations. The goal is to obtain mAbs that react with distinct native epitopes on known and potentially unknown transmission-blocking candidates. It is expected that these mAbs will be useful tools to assess the structure of recombinant proteins and identify transmission-blocking epitopes.